{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:52:57Z","timestamp":1758477177440,"version":"3.44.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:p>5-Aminosalicylate (5-ASA) intolerance complicates ulcerative colitis (UC) management, often necessitating alternative treatment approaches. Granulocyte and monocyte adsorptive apheresis (GMA) has been recognized as a safe treatment option for patients with UC who are refractory or intolerant to conventional drugs, including steroids; however, its effectiveness and safety in patients with 5-ASA intolerance remain unclear. This study aimed to investigate the effectiveness and safety of GMA in patients with UC and 5-ASA intolerance. We conducted a retrospective observational study to evaluate the effectiveness and safety of GMA in patients with UC and 5-ASA intolerance. Eighty-five patients with UC who underwent GMA were assessed, including 21 with 5-ASA intolerance and 64 with 5-ASA tolerance. This study compared the patient characteristics, treatment outcomes, concomitant drugs, and adverse events between the 2 groups. The remission rate was 28.6% (6\/21) in the 5-ASA-intolerant group and 31.3% (20\/64) in the 5-ASA-tolerant group, with no significant difference between the groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.967). Both groups showed significant reductions in the dose of oral prednisolone and Lichtiger clinical activity index scores following the GMA. Our study suggests that GMA is equally effective and safe in 5-ASA-intolerant and 5-ASA-tolerant patients, offering an alternative treatment option in this challenging clinical scenario.<\/jats:p>","DOI":"10.1097\/md.0000000000043389","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:00:30Z","timestamp":1754089230000},"page":"e43389","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis and 5-aminosalicylate intolerance"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4787-1941","authenticated-orcid":false,"given":"Masaki","family":"Kato","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, St. Marianna University School of Medicine, Kawasaki, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuto","family":"Tsukui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyo","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Konno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Kiyokawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-0483","authenticated-orcid":false,"given":"Tsutomu","family":"Sakurada","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, St. Marianna University School of Medicine, Kawasaki, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4279-0138","authenticated-orcid":false,"given":"Tadateru","family":"Maehata","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-5213","authenticated-orcid":false,"given":"Hiroshi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9837-0856","authenticated-orcid":false,"given":"Keisuke","family":"Tateishi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis.","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ajg.2017.470","article-title":"Optimizing selection of biologics in inflammatory bowel disease: development of an online patient decision aid using conjoint analysis.","volume":"113","author":"Almario","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/apt.14669","article-title":"Review article: novel oral-targeted therapies in inflammatory bowel disease.","volume":"47","author":"White","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"101866","DOI":"10.1016\/j.eclinm.2023.101866","article-title":"Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis.","volume":"57","author":"Attauabi","year":"2023","journal-title":"EClinicalMedicine"},{"key":"R5-20250918","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment.","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease.","volume":"53","author":"Matsuoka","year":"2018","journal-title":"J Gastroenterol"},{"key":"R7-20250918","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1590-8658(01)80108-0","article-title":"Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects.","volume":"33","author":"Di Paolo","year":"2001","journal-title":"Dig Liver Dis"},{"key":"R8-20250918","first-page":"73","article-title":"Mesalamine intolerance mimics symptoms of active inflammatory bowel disease.","volume":"34","author":"Iofel","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4292\/wjgpt.v1.i6.132","article-title":"Mesalamine induced symptom exacerbation of ulcerative colitis: case report and brief discussion.","volume":"1","author":"Gupta","year":"2010","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/00365521.2014.962608","article-title":"Ulcerative colitis patients with an inflammatory response upon mesalazine cannot be desensitized: a randomized study.","volume":"50","author":"Buurman","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"R11-20250918","doi-asserted-by":"crossref","first-page":"S801","DOI":"10.14309\/00000434-201710001-01464","article-title":"Mesalamine-induced acute intolerance syndrome with associated mucosal inflammation.","volume":"112","author":"Thomson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R12-20250918","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12876-019-1049-2","article-title":"The culprit of mesalamine intolerance: case series and literature review.","volume":"19","author":"Xie","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/ped.13235","article-title":"5-Aminosalicylate intolerance causing exacerbation in pediatric ulcerative colitis.","volume":"59","author":"Shimizu","year":"2017","journal-title":"Pediatr Int"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5217\/ir.2018.16.2.273","article-title":"Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy.","volume":"16","author":"Saito","year":"2018","journal-title":"Intest Res"},{"key":"R15-20250918","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/jgh.15138","article-title":"Multicenter survey on mesalamine intolerance in patients with ulcerative colitis.","volume":"36","author":"Hiraoka","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R16-20250918","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5217\/ir.2019.00084","article-title":"5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis.","volume":"18","author":"Mizuno","year":"2020","journal-title":"Intest Res"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"22176","DOI":"10.1038\/s41598-020-79207-z","article-title":"Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease.","volume":"10","author":"Matsumoto","year":"2020","journal-title":"Sci Rep"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ibd\/izab004","article-title":"Genetic background of mesalamine-induced fever and diarrhea in Japanese patients with inflammatory bowel disease.","volume":"28","author":"Suzuki","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3164\/jcbn.22-33","article-title":"Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis.","volume":"71","author":"Minagawa","year":"2022","journal-title":"J Clin Biochem Nutr"},{"key":"R20-20250918","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/apt.16120","article-title":"5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis.","volume":"53","author":"Hibiya","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"R21-20250918","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","article-title":"Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes.","volume":"7","author":"Saniabadi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"R22-20250918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J Clin Apher"},{"key":"R23-20250918","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00535-004-1465-z","article-title":"Adsorptive granulocyte and monocyte apheresis for refractory Crohn\u2019s disease: an open multicenter prospective study.","volume":"39","author":"Fukuda","year":"2004","journal-title":"J Gastroenterol"},{"key":"R24-20250918","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/1346-8138.13975","article-title":"Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: efficacy of a non-drug intervention for patients refractory to pharmacologics.","volume":"44","author":"Kanekura","year":"2017","journal-title":"J Dermatol"},{"key":"R25-20250918","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jaad.2012.09.037","article-title":"Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis.","volume":"68","author":"Ikeda","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R26-20250918","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.dld.2008.11.020","article-title":"Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan.","volume":"41","author":"Hibi","year":"2009","journal-title":"Dig Liver Dis"},{"key":"R27-20250918","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41424-018-0037-0","article-title":"A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.","volume":"9","author":"Yamamoto","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"R28-20250918","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jca.21670","article-title":"Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: concepts and clinical features for better therapeutic outcomes.","volume":"34","author":"Saniabadi","year":"2019","journal-title":"J Clin Apher"},{"key":"R29-20250918","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3892\/etm.2022.11463","article-title":"Use of granulocyte and monocyte adsorption apheresis in dermatology (review).","volume":"24","author":"Gnesotto","year":"2022","journal-title":"Exp Ther Med"},{"key":"R30-20250918","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12876-019-1110-1","article-title":"Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.","volume":"19","author":"Motoya","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"R31-20250918","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jca.21631","article-title":"Efficacy and safety of granulocyte adsorption apheresis in elderly patients with ulcerative colitis.","volume":"33","author":"Ito","year":"2018","journal-title":"J Clin Apher"},{"key":"R32-20250918","doi-asserted-by":"crossref","first-page":"5302885","DOI":"10.1155\/2021\/5302885","article-title":"Granulomonocytapheresis using the single-needle method for a girl with ulcerative colitis.","volume":"2021","author":"Sasaki","year":"2021","journal-title":"Case Rep Med"},{"key":"R33-20250918","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy.","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"R34-20250918","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/ajg.2009.453","article-title":"An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.","volume":"104","author":"Sakuraba","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R35-20250918","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2222.1997.tb00690.x","article-title":"The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity.","volume":"27","author":"Nyfeler","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"R36-20250918","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000528185","article-title":"Effectiveness and safety of golimumab in the treatment of ulcerative colitis: 52-week results from post-marketing surveillance in Japan.","volume":"7","author":"Nakamura","year":"2022","journal-title":"Inflamm Intest Dis"},{"key":"R37-20250918","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk.","volume":"19","author":"Kanis","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R38-20250918","doi-asserted-by":"crossref","first-page":"e0158017","DOI":"10.1371\/journal.pone.0158017","article-title":"Corticosteroid use and complications in a US inflammatory bowel disease cohort.","volume":"11","author":"Waljee","year":"2016","journal-title":"PLoS One"},{"key":"R39-20250918","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.cgh.2008.06.010","article-title":"Relationships between disease activity and serum and fecal biomarkers in patients with Crohn\u2019s disease.","volume":"6","author":"Jones","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R40-20250918","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","article-title":"Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.","volume":"103","author":"Langhorst","year":"2008","journal-title":"Am J Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:00:47Z","timestamp":1758232847000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":40,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043389","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"2024-10-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}